Chinese medicine companies do not have extraction capacity to close in 2016

The State Food and drug administration has issued a draft for comments (hereinafter referred to as the draft for comments) on the notice on strengthening the supervision and administration of extraction and extraction of traditional Chinese medicine, which is strictly regulated According to the draft, as of January 1, 2016, all Chinese patent drug manufacturers without the ability to extract traditional Chinese medicine will stop the production of corresponding varieties, and the approved entrusted processing will be abolished After the expiration of the period of validity of the Chinese herbal extracts which have obtained the drug approval number, the provincial food and drug administration shall not re register them For the traditional Chinese medicine extracts which are clearly downloaded from the national drug standards and have separate national drug standards, the filing management shall be implemented Since January 1, 2015, all extracts of traditional Chinese medicine not filed as required shall not be used in the production of proprietary Chinese medicine Some insiders pointed out that traditional Chinese medicine extract is the mainstream of traditional Chinese medicine export At present, relevant departments are carrying out the revision of 2015 edition of Chinese Pharmacopoeia After 27 new pharmacopoeia in 2010 edition, the 2015 edition of Chinese Pharmacopoeia plans to add 60 new varieties of traditional Chinese medicine extract Plant extract is the most likely sub industry to realize internationalization in the field of traditional Chinese medicine The new policy will promote the quality of products and accelerate the process of internationalization of traditional Chinese medicine.